Dr. Charles W. Bryan, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Southwestern Medical School at Dallas (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,047
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of Texas Southwestern Medical School at Dallas
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NC license 34258 -
Hematology (Internal Medicine) Physician
NC license 34258 -
Medical Oncology Physician
NC license 34258
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Mission Hospital and Asheville Surgery Ce Asheville, NC
- Haywood Regional Medical Center Clyde, NC
- The Mcdowell Hospital Marion, NC
- Blue Ridge Regional Hospital Spruce Pine, NC
Medical groups
- American Oncology PArtners PA (391 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,047
- Services billed
- 140,393
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, aprepitant, 1 mg | 9,900 | 46 |
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 9,180 | 15 |
| Injection, nivolumab, 1 mg | 7,500 | 12 |
| Injection, pembrolizumab, 1 mg | 6,900 | 24 |
| Injection, oxaliplatin, 0.5 mg | 6,704 | 14 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,780 | 14 |
| Injection, denosumab, 1 mg | 3,240 | 23 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,375 | 23 |
| Injection, bortezomib, 0.1 mg | 2,170 | 16 |
| Injection, paclitaxel, 1 mg | 2,113 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Asheville, NC | 117 |
| Prednisone Other prescribers in Asheville, NC | 84 |
| Abiraterone Acetate | 75 |
| Revlimid (lenalidomide) | 66 |
| Eliquis (apixaban) Other prescribers in Asheville, NC | 57 |
| Oxycodone Hcl Other prescribers in Asheville, NC | 45 |
| Omeprazole Other prescribers in Asheville, NC | 43 |
| Xtandi (enzalutamide) | 37 |
| Ondansetron Odt (ondansetron) Other prescribers in Asheville, NC | 34 |
| Lupron Depot (leuprolide acetate) | 33 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 15 payments worth $352 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $89.90 |
|---|---|
| Pfizer Inc. | $44.37 |
| Merck Sharp & Dohme LLC | $41.44 |
| AstraZeneca Pharmaceuticals LP | $30.68 |
| Exelixis Inc. | $29.62 |
| Array Biopharma Inc | $23.78 |
| AbbVie Inc. | $23.31 |
| Syndax Pharmaceuticals, Inc. | $18.92 |
| Food and Beverage | $352 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.